Drugs / IMMUNATE SD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00162019 | Mar 2003 → Aug 2004 | hemophilia A | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMMUNATE SD | “Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients” NCT00162019 ↗ |
| Known as | IMMUNATE Solvent Detergent | “Phase 3, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of IMMUNATE Solvent Detergent (IMMUNATE SD) in Previously Treated...” NCT00162019 ↗ |
| Modality | Protein / enzyme biologic | “Human Plasma-Derived Coagulation Factor VIII Concentrate” NCT00162019 ↗ |